TC
RYTM icon

Truvestments Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History

Truvestments Capital’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Hold
138
– – ﹤0.01% 724
2026
Q1 		$12K Hold
138
– – ﹤0.01% 728
2025
Q4 		$14.8K Hold
138
– – ﹤0.01% 636
2025
Q3 		$13.9K Hold
138
– – ﹤0.01% 657
2025
Q2 		$8.72K Hold
138
– – ﹤0.01% 660
2025
Q1 		$7.31K Hold
138
– – ﹤0.01% 701
2024
Q4 		$7.72K Hold
138
– – ﹤0.01% 645
2024
Q3 		$7.23K Buy
+138
New +$6.61K ﹤0.01% 627
2024
Q2 		– Sell
-216
Closed -$9.36K – 593
2024
Q1 		$9.36K Hold
216
– – ﹤0.01% 503
2023
Q4 		$9.93K Hold
216
– – ﹤0.01% 519
2023
Q3 		$4.95K Hold
216
– – ﹤0.01% 514
2023
Q2 		$3.56K Hold
216
– – ﹤0.01% 561
2023
Q1 		$3.85K Buy
+216
New +$5.42K ﹤0.01% 533

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Truvestments Capital's RYTM Position: Q2 2026 in Review

Truvestments Capital held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 138 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Truvestments Capital first reported a position in RYTM in Q1 2023 and has held it in 13 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Truvestments Capital held 138 shares of Rhythm Pharmaceuticals worth $15.3K as of Q2 2026.
  • Truvestments Capital left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #724 holding.
  • Truvestments Capital first reported a position in Rhythm Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.